Back to 
Sculptor Capital LP
Sculptor Capital LP
CRL
Showing 0 of 13 quarters
Position history for Sculptor Capital LP's holdings in Charles River Laboratories International, Inc.
No. Sculptor Capital exited its CRL (Charles River Laboratories International) position in Q1 2022. Its Q4 2021 13F listed 18,582 shares worth $7M. Sculptor Capital already held CRL in its Q1 2019 13F, the earliest on record, and held it in 12 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.